Literature DB >> 7934822

The ferric iron-binding protein of pathogenic Neisseria spp. functions as a periplasmic transport protein in iron acquisition from human transferrin.

C Y Chen1, S A Berish, S A Morse, T A Mietzner.   

Abstract

The ferric iron-binding protein (Fbp) expressed by pathogenic Neisseria spp. has been proposed to play a central role in the high-affinity acquisition of iron from human transferrin. The results of this investigation provide evidence that Fbp participates in this process as a functional analogue of a Gram-negative periplasmic-binding protein component, which operates as a part of a general active transport process for the receptor-mediated, high-affinity transport of iron from human transferrin. Known properties of Fbp are correlated with those of other well-characterized periplasmic-binding proteins, including structural features and the reversible binding of ligand. Predictive of a periplasmic-binding protein, which functions in the high-affinity acquisition of iron, is that Fbp is a transient participant in the process of iron acquisition from human transferrin. Evidence for this is demonstrated by results of pulse-chase experiments. Taken together, the data described here and elsewhere suggest that pathogenic Neisseria spp. use a periplasmic-binding protein-mediated active transport mechanism for the acquisition of iron from human transferrin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7934822     DOI: 10.1111/j.1365-2958.1993.tb01957.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  42 in total

1.  fbpABC gene cluster in Neisseria meningitidis is transcribed as an operon.

Authors:  H H Khun; V Deved; H Wong; B C Lee
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Point mutations in HpuB enable gonococcal HpuA deletion mutants to grow on hemoglobin.

Authors:  Ching-Ju Chen; Dalton Mclean; Christopher E Thomas; James E Anderson; P Frederick Sparling
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

Review 3.  The role of ATP-binding cassette transporters in bacterial pathogenicity.

Authors:  Victoria G Lewis; Miranda P Ween; Christopher A McDevitt
Journal:  Protoplasma       Date:  2012-01-13       Impact factor: 3.356

4.  Fur-mediated activation of gene transcription in the human pathogen Neisseria gonorrhoeae.

Authors:  Chunxiao Yu; Caroline Attardo Genco
Journal:  J Bacteriol       Date:  2012-01-27       Impact factor: 3.490

5.  High-affinity binding by the periplasmic iron-binding protein from Haemophilus influenzae is required for acquiring iron from transferrin.

Authors:  Ali G Khan; Stephen R Shouldice; Shane D Kirby; Rong-hua Yu; Leslie W Tari; Anthony B Schryvers
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

6.  The fbpABC operon is required for Ton-independent utilization of xenosiderophores by Neisseria gonorrhoeae strain FA19.

Authors:  Heather R Strange; Tracey A Zola; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

7.  Structure of the Escherichia coli phosphonate binding protein PhnD and rationally optimized phosphonate biosensors.

Authors:  Ismael Alicea; Jonathan S Marvin; Aleksandr E Miklos; Andrew D Ellington; Loren L Looger; Eric R Schreiter
Journal:  J Mol Biol       Date:  2011-10-12       Impact factor: 5.469

8.  A Neisseria meningitidis fbpABC mutant is incapable of using nonheme iron for growth.

Authors:  H H Khun; S D Kirby; B C Lee
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

9.  Characterization of a periplasmic protein involved in iron utilization of Actinobacillus actinomycetemcomitans.

Authors:  P T Willemsen; I Vulto; M Boxem; J de Graaff
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

10.  Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni.

Authors:  Claire E Miller; Jonathan D Rock; Kristian A Ridley; Peter H Williams; Julian M Ketley
Journal:  J Bacteriol       Date:  2008-01-18       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.